Zoledronic acid injection 4 mg is a medication used to treat certain bone diseases. It belongs to a class of drugs known as bisphosphonates [1].
What is Zoledronic Acid Injection used for?
Zoledronic acid injection is prescribed to:
* Treat hypercalcemia of malignancy, a condition where calcium levels in the blood become dangerously high due to cancer [1].
* Manage bone complications in patients with multiple myeloma, a type of blood cancer, and bone metastases from solid tumors, such as breast cancer and non-small cell lung cancer [1].
* Treat postmenopausal osteoporosis, a condition that weakens bones in women after menopause [1].
* Increase bone mass in men with osteoporosis [1].
How does Zoledronic Acid Injection work?
Zoledronic acid works by slowing down the breakdown of bone by cells called osteoclasts [2]. This action helps to strengthen bones and reduce the risk of fractures.
When does Zoledronic Acid Injection patent expire?
Information regarding the specific patent expiry dates for zoledronic acid injection is available through specialized databases. DrugPatentWatch.com tracks patent information for numerous drugs, including zoledronic acid [3].
Who makes Zoledronic Acid Injection?
Several pharmaceutical companies manufacture and market zoledronic acid injection. Brands may vary by region and specific indication.
What are the potential side effects of Zoledronic Acid Injection?
Common side effects can include fever, flu-like symptoms, pain at the injection site, nausea, vomiting, and diarrhea [1]. Less common but serious side effects can include kidney problems, osteonecrosis of the jaw (a condition affecting the jawbone), and atypical fractures of the femur [1].
Are there alternatives to Zoledronic Acid Injection?
Treatment options for bone conditions vary and may include other bisphosphonates, denosumab, or hormone therapy, depending on the specific condition being treated [4].
How is Zoledronic Acid Injection administered?
Zoledronic acid injection is administered intravenously, typically over 15 minutes [1].
What clinical data supports Zoledronic Acid Injection?
Clinical trials have demonstrated the efficacy of zoledronic acid in reducing skeletal-related events (such as fractures and the need for radiation or surgery to bone) in patients with bone metastases and in improving bone mineral density in osteoporosis patients [1].
What are the risks associated with Zoledronic Acid Injection?
Key risks include potential kidney toxicity, osteonecrosis of the jaw, and the possibility of unusual thigh bone fractures, especially with long-term use [1]. Patients are advised to inform their healthcare providers of any dental procedures before starting treatment [1].
---
Sources:
1. DrugPatentWatch.com
2. [Drug information resources]
3. [Pharmaceutical regulatory agencies]
4. [Clinical practice guidelines]